Here, we have demonstrated that for ALT-pathway activity in glioma (and possibly other ALT-cancer types), the proximal genetic causation is ATRX loss, whilst the evolutionary causation can be accumulation of ROS (Fig. 8A). This evidence concerns the gene ATRX and central nervous system cancer.